CUA guideline on adult overactive bladder.
作者信息
Corcos Jacques, Przydacz Mikolaj, Campeau Lysanne, Gray Gary, Hickling Duane, Honeine Christiane, Radomski Sidney B, Stothers Lynn, Wagg Adrian, Lond Frcp
机构信息
Department of Urology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Northern Alberta Urology Centre, Edmonton, AB, Canada.
出版信息
Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9.
Abstract
摘要
相似文献
1
CUA guideline on adult overactive bladder.加拿大泌尿外科学会成人膀胱过度活动症指南
Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9.
2
Appendix: Executive summary of CUA guideline on adult overactive bladder.附录：加拿大泌尿协会成人膀胱过度活动症指南执行摘要
Can Urol Assoc J. 2017 May;11(5):E248-E249. doi: 10.5489/cuaj.4694. Epub 2017 May 9.
3
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.2023年更新——加拿大泌尿外科协会指南：囊性肾病变的管理 在最初发布（2017年3月）之前，本指南经过了加拿大泌尿外科协会指南委员会、广大加拿大泌尿外科协会成员以及加拿大泌尿外科协会执行委员会的审查。2023年的更新内容已获加拿大泌尿外科协会指南委员会和加拿大泌尿外科协会执行委员会批准。
Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389.
4
European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.欧洲泌尿外科学会女性非神经源性下尿路症状诊断与管理指南。第 1 部分：诊断、膀胱过度活动症、压力性尿失禁和混合性尿失禁。
Eur Urol. 2022 Jul;82(1):49-59. doi: 10.1016/j.eururo.2022.01.045. Epub 2022 Feb 23.
5
Nocturia Quality-of-Life questionnaire is a useful tool to predict nocturia and a risk of falling in Japanese outpatients: a cross-sectional survey.夜尿症生活质量问卷是预测日本门诊患者夜尿症和跌倒风险的有用工具：一项横断面调查。
Int J Urol. 2014 Mar;21(3):289-93. doi: 10.1111/iju.12242. Epub 2013 Aug 29.
6
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019.成人过度活动膀胱（非神经性）的诊断和治疗：2019 年 AUA/SUFU 指南修订版。
J Urol. 2019 Sep;202(3):558-563. doi: 10.1097/JU.0000000000000309. Epub 2019 Aug 8.
7
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE).非肌肉浸润性膀胱癌指南（欧洲泌尿外科学会、加拿大泌尿外科学会、美国泌尿外科学会、美国国立综合癌症网络、英国国家卫生与临床优化研究所）比较
Bladder Cancer. 2016 Jan 7;2(1):27-36. doi: 10.3233/BLC-150034.
8
The Overactive Bladder and the AUA Guidelines: A Proposed Clinical Pathway for Evaluation and Effective Management in a Contemporary Urology Practice.膀胱过度活动症与美国泌尿外科学会指南：当代泌尿外科实践中评估与有效管理的拟议临床路径
Urol Pract. 2016 Sep;3(5):399-405. doi: 10.1016/j.urpr.2016.01.004. Epub 2016 Jul 1.
9
The patient perspective on overactive bladder: a mixed-methods needs assessment.膀胱过度活动症患者的观点：一项混合方法需求评估。
BMC Fam Pract. 2014 May 14;15:96. doi: 10.1186/1471-2296-15-96.
10
Treatments for overactive bladder: focus on pharmacotherapy.膀胱过度活动症的治疗：聚焦药物治疗。
J Obstet Gynaecol Can. 2012 Nov;34(11):1092-1101. doi: 10.1016/S1701-2163(16)35440-8.
引用本文的文献
1
Overactive bladder drugs and the risk of dementia.膀胱过度活动症药物与痴呆风险
BMJ Med. 2025 Apr 15;4(1):e001520. doi: 10.1136/bmjmed-2025-001520. eCollection 2025.
2
Comparative efficacy and adverse effects of β3-agonists and antimuscarinics in overactive bladder: a network and component network meta-analysis.β3 激动剂与抗毒蕈碱药物治疗膀胱过度活动症的疗效及不良反应比较：网状和成分网状荟萃分析
Eur J Clin Pharmacol. 2025 Jun 7. doi: 10.1007/s00228-025-03855-1.
3
Women suffering from overactive bladder syndrome exhibit a higher urethral viral abundance compared to healthy controls: a pilot study.与健康对照相比，患有膀胱过度活动症的女性尿道病毒丰度更高：一项试点研究。
Sci Rep. 2025 Jun 3;15(1):19484. doi: 10.1038/s41598-025-98780-9.
4
Association between triglyceride glucose-waist height ratio index and overactive bladder: based on NHANES 2005-2018.甘油三酯葡萄糖-腰围身高比指数与膀胱过度活动症之间的关联：基于2005 - 2018年美国国家健康与营养检查调查（NHANES）
Front Endocrinol (Lausanne). 2025 Apr 15;16:1541218. doi: 10.3389/fendo.2025.1541218. eCollection 2025.
5
Efficacy and safety of Solifenacin combined with Mirabegron in treating overactive bladder in female patients following bladder instillation for bladder cancer.索利那新联合米拉贝隆治疗膀胱癌膀胱灌注术后女性膀胱过度活动症的疗效和安全性。
Am J Transl Res. 2025 Feb 15;17(2):1144-1152. doi: 10.62347/BXQN5596. eCollection 2025.
6
Lidocaine solution vs. lidocaine gel instillation for pain management during intravesical botulinum injections.膀胱内注射肉毒杆菌毒素时，利多卡因溶液与利多卡因凝胶滴注用于疼痛管理的比较
Can Urol Assoc J. 2025 Jun;19(6):189-192. doi: 10.5489/cuaj.9011.
7
Efficacy and safety of sacral nerve root magnetic stimulation combined with solifenacin in female patients with overactive bladder.骶神经根磁刺激联合索利那新治疗女性膀胱过度活动症的疗效与安全性
Am J Transl Res. 2025 Jan 15;17(1):685-692. doi: 10.62347/EHTT9544. eCollection 2025.
8
Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study.盆底磁刺激联合米拉贝隆治疗女性难治性膀胱过度活动症的疗效与安全性：一项前瞻性研究
Front Neurosci. 2024 Apr 10;18:1373375. doi: 10.3389/fnins.2024.1373375. eCollection 2024.
9
2024 Canadian Urological Association guideline: Female stress urinary incontinence.2024年加拿大泌尿外科学会指南：女性压力性尿失禁
Can Urol Assoc J. 2024 Apr;18(4):83-102. doi: 10.5489/cuaj.8751.
10
Radiofrequency as the New Opportunity in Treating Overactive Bladder and Urge Urinary Incontinence-A Single-Arm Pilot Study.射频治疗膀胱过度活动症和急迫性尿失禁的新机遇：单臂先导研究。
Medicina (Kaunas). 2024 Jan 24;60(2):197. doi: 10.3390/medicina60020197.
本文引用的文献
1
Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial.在职人员对高剂量抗毒蕈碱疗法的治疗依从性：一项随机试验。
Ther Adv Urol. 2016 Aug;8(4):239-248. doi: 10.1177/1756287216652030. Epub 2016 Jun 3.
2
Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer.使用治疗模式分析仪评估综合医疗服务体系中膀胱过度活动症患者的治疗结果。
Am Health Drug Benefits. 2016 Sep;9(6):343-353.
3
Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population.在相对年轻的成年男性人群中对膀胱过度活动症和急迫性尿失禁与阻塞性睡眠呼吸暂停综合征之间关联的批判性评估。
Neurourol Urodyn. 2017 Sep;36(7):1804-1808. doi: 10.1002/nau.23184. Epub 2016 Dec 6.
4
Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial.米拉贝隆与索利那新治疗女性膀胱过度活动症的长期疗效比较：一项前瞻性随机试验
Low Urin Tract Symptoms. 2018 May;10(2):148-152. doi: 10.1111/luts.12151. Epub 2016 Dec 2.
5
Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?泌尿外科手术前对无症状菌尿进行评估和治疗对于降低术后有症状尿路感染的风险是否必要？
Urology. 2017 Jan;99:100-105. doi: 10.1016/j.urology.2016.10.016. Epub 2016 Oct 20.
6
Social Media in Urology: opportunities, applications, appropriate use and new horizons.泌尿外科中的社交媒体：机遇、应用、合理使用及新视野
Cent European J Urol. 2016;69(3):293-298. doi: 10.5173/ceju.2016.848. Epub 2016 Sep 16.
7
The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population.临床膀胱过度活动症患者中抑郁症与膀胱过度活动症/尿失禁症状之间的关系。
BMC Urol. 2016 Oct 6;16(1):60. doi: 10.1186/s12894-016-0179-x.
8
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.A型肉毒毒素与骶神经调节治疗女性难治性急迫性尿失禁的随机临床试验
JAMA. 2016 Oct 4;316(13):1366-1374. doi: 10.1001/jama.2016.14617.
9
Evaluation and management of overactive bladder: strategies for optimizing care.膀胱过度活动症的评估与管理：优化护理的策略
Res Rep Urol. 2016 Jul 27;8:113-22. doi: 10.2147/RRU.S93636. eCollection 2016.
10
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).米拉贝隆与索利那新联合治疗膀胱过度活动症患者：一项随机、双盲、析因、剂量范围探索的II期研究（SYMPHONY）的疗效探索性应答者分析及患者报告结局评估
World J Urol. 2017 May;35(5):827-838. doi: 10.1007/s00345-016-1908-1. Epub 2016 Aug 11.
Zotero 插件